Company Search:
Advanced Search
Sponsored Links
Takara Bio Inc Company Snapshot
Takara Bio Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Takara Bio Inc with three other companies in this sector in Japan: Linical Company Limited (2018 sales of 9.11 billion Japanese Yen [US$82.38 million] of which 90% was Cro Business), Shin Nippon Biomedical Laboratories Ltd (16.60 billion Japanese Yen [US$150.07 million] of which 84% was Pre-Clinical Business), and Morishita Jintan Co., Ltd. (10.80 billion Japanese Yen [US$97.63 million] of which 75% was Health Care Business).

Sales Analysis. Takara Bio Inc reported sales of ¥32.31 billion (US$292.10 million) for the fiscal year ending March of 2018. This represents an increase of 10.0% versus 2017, when the company's sales were ¥29.38 billion. Sales of Bio Support saw an increase of 11.3% in 2018, from ¥26.57 billion to ¥29.57 billion. Not all segments of Takara Bio Inc experienced an increase in sales in 2018: sales of Food and Bio Medical fell 2.5% to ¥2.24 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Takara Bio Inc
  Stock Performance Chart for Takara Bio Inc
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 2,331.00
(Figures in Japanese Yen)
1 Week 1.5%   13 Weeks -13.0%  
4 Weeks -6.3%   52 Weeks 19.5%  
Takara Bio Inc Key Data:
  Ticker: 4974 Country: Japan
  Exchanges: TYO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 32,312,000,000
(Year Ending Jan 2019).
Employees: 1,448
  Currency: Japanese Yen Market Cap: 280,688,763,600
  Fiscal Yr Ends: March Shares Outstanding: 120,415,600
  Share Type: Common Closely Held Shares: 73,350,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.